{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:23:59Z","timestamp":1772133839140,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1128864"],"award-info":[{"award-number":["APP1128864"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1188348"],"award-info":[{"award-number":["APP1188348"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1188348"],"award-info":[{"award-number":["APP1188348"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1128864"],"award-info":[{"award-number":["APP1128864"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["Cardiovascular Grant - EMCR"],"award-info":[{"award-number":["Cardiovascular Grant - EMCR"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ghrelin is commonly known as the \u2018hunger hormone\u2019 due to its role in stimulating food intake in humans. However, the roles of ghrelin extend beyond regulating hunger. Our aim was to investigate the ability of ghrelin to protect against hydrogen peroxide (H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>), a reactive oxygen species commonly associated with cardiac injury. An in vitro model of oxidative stress was developed using H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> injured H9c2 cells. Despite lentiviral ghrelin overexpression, H9c2 cell viability and mitochondrial function were not protected following H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> injury. We found that H9c2 cells lack expression of the preproghrelin cleavage enzyme prohormone convertase 1 (encoded by <jats:italic>PCSK1<\/jats:italic>), required to convert ghrelin to its active form. In contrast, we found that primary rat cardiomyocytes do express <jats:italic>PCSK1<\/jats:italic> and were protected from H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> injury by lentiviral ghrelin overexpression. In conclusion, we have shown that ghrelin expression can protect primary rat cardiomyocytes against H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>, though this effect was not observed in other cell types tested.<\/jats:p>","DOI":"10.1038\/s41434-023-00435-9","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:02:05Z","timestamp":1704355325000},"page":"165-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ghrelin mediated cardioprotection using in vitro models of oxidative stress"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3086-7097","authenticated-orcid":false,"given":"Cindy Y.","family":"Kok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4161-0820","authenticated-orcid":false,"given":"George","family":"Ghossein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu","family":"Igoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuka","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-1989","authenticated-orcid":false,"given":"Tracy","family":"Titus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2592-4555","authenticated-orcid":false,"given":"Shinya","family":"Tsurusaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5201-4856","authenticated-orcid":false,"given":"James JH.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-6720","authenticated-orcid":false,"given":"Eddy","family":"Kizana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"435_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/01.CIR.75.6.1237","volume":"75","author":"A Uraizee","year":"1987","unstructured":"Uraizee A, Reimer KA, Murry CE, Jennings RB. Failure of superoxide dismutase to limit size of myocardial infarction after 40\u2009min of ischemia and 4 days of reperfusion in dogs. Circulation. 1987;75:1237\u201348.","journal-title":"Circulation"},{"key":"435_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1008830129106","volume":"5","author":"CM Venturini","year":"1998","unstructured":"Venturini CM, Flickinger AG, Womack CR, Smith ME, McMahon EG. The antioxidant, N-(2-mercaptopropionyl)-glycine (MPG), does not reduce myocardial infarct size in an acute canine model of myocardial ischemia and reperfusion. J Thromb Thrombolysis. 1998;5:135\u201341.","journal-title":"J Thromb Thrombolysis"},{"key":"435_CR3","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/01.CIR.89.5.1982","volume":"89","author":"JT Flaherty","year":"1994","unstructured":"Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation. 1994;89:1982\u201391.","journal-title":"Circulation"},{"key":"435_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.freeradbiomed.2017.04.027","volume":"108","author":"KJ Bubb","year":"2017","unstructured":"Bubb KJ, Kok C, Tang O, Rasko NB, Birgisdottir AB, Hansen T, et al. The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling. Free Radic Biol Med. 2017;108:585\u201394.","journal-title":"Free Radic Biol Med"},{"key":"435_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2021.03.045","volume":"169","author":"M Bartekov\u00e1","year":"2021","unstructured":"Bartekov\u00e1 M, Adameov\u00e1 A, G\u00f6rbe A, Ferenczyov\u00e1 K, Pech\u00e1\u0148ov\u00e1 O, Lazou A, et al. Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases. Free Radic Biol Med. 2021;169:446\u201377.","journal-title":"Free Radic Biol Med"},{"key":"435_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5603\/CJ.a2013.0051","volume":"21","author":"M Mohammadshahi","year":"2014","unstructured":"Mohammadshahi M, Haidari F, Soufi F. Chronic resveratrol administration improves diabetic cardiomyopathy in part by reducing oxidative stress. Cardiol J. 2014;21:39\u201346.","journal-title":"Cardiol J"},{"key":"435_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1211\/jpp.61.10.0014","volume":"61","author":"A Annapurna","year":"2010","unstructured":"Annapurna A, Reddy CS, Akondi RB, Rao SRC. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. J Pharmacy Pharmacol. 2010;61:1365\u201374.","journal-title":"J Pharmacy Pharmacol"},{"key":"435_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1017\/S0007114515005310","volume":"115","author":"Y Shi","year":"2016","unstructured":"Shi Y, Williamson G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial. Br J Nutr. 2016;115:800\u20136.","journal-title":"Br J Nutr"},{"key":"435_CR9","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1161\/hc4501.098928","volume":"104","author":"TP Cappola","year":"2001","unstructured":"Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001;104:2407\u201311.","journal-title":"Circulation"},{"key":"435_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cardfail.2006.05.005","volume":"12","author":"HE Cingolani","year":"2006","unstructured":"Cingolani HE, Plastino JA, Escudero EM, Mangal B, Brown J, P\u00e9rez NG. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail. 2006;12:491\u20138.","journal-title":"J Card Fail"},{"key":"435_CR11","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","volume":"51","author":"JM Hare","year":"2008","unstructured":"Hare JM, Mangal B, Brown J, Fisher C Jr, Freudenberger R, Colucci WS, et al. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol. 2008;51:2301\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"435_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jb\/mvr134","volume":"151","author":"T Sato","year":"2012","unstructured":"Sato T, Nakamura Y, Shiimura Y, Ohgusu H, Kangawa K, Kojima M. Structure, regulation and function of ghrelin. J Biochem. 2012;151:119\u201328.","journal-title":"J Biochem"},{"key":"435_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejphar.2010.12.011","volume":"654","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Huang W-D, Lv X-Y, Yang Y-M. Ghrelin protects H9c2 cells from hydrogen peroxide-induced apoptosis through NF-\u03baB and mitochondria-mediated signaling. Eur J Pharmacol. 2011;654:142\u20139.","journal-title":"Eur J Pharmacol"},{"key":"435_CR14","doi-asserted-by":"publisher","first-page":"1385138","DOI":"10.1155\/2020\/1385138","volume":"2020","author":"Y Akalu","year":"2020","unstructured":"Akalu Y, Molla MD, Dessie G, Ayelign B. Physiological effect of ghrelin on body systems. Int J Endocrinol. 2020;2020:1385138.","journal-title":"Int J Endocrinol"},{"key":"435_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.peptides.2013.08.015","volume":"48","author":"G-G Zhang","year":"2013","unstructured":"Zhang G-G, Cai H-Q, Li Y-H, Sui Y-B, Zhang J-S, Chang J-R, et al. Ghrelin protects heart against ERS-induced injury and apoptosis by activating AMP-activated protein kinase. Peptides. 2013;48:156\u201365.","journal-title":"Peptides"},{"key":"435_CR16","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1038\/ncomms8388","volume":"6","author":"G Ruozi","year":"2015","unstructured":"Ruozi G, Bortolotti F, Falcione A, Dal Ferro M, Ukovich L, Macedo A, et al. AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia. Nat Commun. 2015;6:7388\u20137388.","journal-title":"Nat Commun"},{"key":"435_CR17","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1210\/jcem.86.12.8115","volume":"86","author":"N Nagaya","year":"2001","unstructured":"Nagaya N, Miyatake K, Uematsu M, Oya H, Shimizu W, Hosoda H, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab. 2001;86:5854\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"435_CR18","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/eurheartj\/ehad100","volume":"44","author":"LH Lund","year":"2023","unstructured":"Lund LH, Hage C, Pironti G, Thorvaldsen T, Ljung-Fax\u00e9n U, Zabarovskaja S, et al. Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization. Eur Heart J. 2023;44:2009\u201325.","journal-title":"Eur Heart J"},{"key":"435_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/eje.0.1500447","volume":"150","author":"T Akamizu","year":"2004","unstructured":"Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 2004;150:447\u201355.","journal-title":"Eur J Endocrinol"},{"key":"435_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases6020042","volume":"6","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom K. Viral vectors in gene therapy. Diseases. 2018;6:42.","journal-title":"Diseases"},{"key":"435_CR21","doi-asserted-by":"publisher","first-page":"H449","DOI":"10.1152\/ajpheart.00896.2002","volume":"285","author":"S Iravanian","year":"2003","unstructured":"Iravanian S, Nabutovsky Y, Kong CR, Saha S, Bursac N, Tung L. Functional reentry in cultured monolayers of neonatal rat cardiac cells. Am J Physiol Heart Circ Physiol. 2003;285:H449\u201356.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"435_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1210\/er.2015-1117","volume":"37","author":"P Stijnen","year":"2016","unstructured":"Stijnen P, Ramos-Molina B, O\u2019Rahilly S, Creemers JW. PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders. Endocr Rev. 2016;37:347\u201371.","journal-title":"Endocr Rev"},{"key":"435_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, et al. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014;11:855\u201360.","journal-title":"Nat Methods"},{"key":"435_CR24","doi-asserted-by":"publisher","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","volume":"109","author":"X Lian","year":"2012","unstructured":"Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA. 2012;109:E1848\u201357.","journal-title":"Proc Natl Acad Sci USA"},{"key":"435_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94732-1","volume":"11","author":"T Grancharova","year":"2021","unstructured":"Grancharova T, Gerbin KA, Rosenberg AB, Roco CM, Arakaki JE, DeLizo CM, et al. A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes. Sci Reps. 2021;11:15845.","journal-title":"Sci Reps"},{"key":"435_CR26","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/en.2011-0090","volume":"152","author":"JY Lee","year":"2011","unstructured":"Lee JY, Oh TH, Yune TY. Ghrelin inhibits hydrogen peroxide-induced apoptotic cell death of oligodendrocytes via ERK and p38MAPK naling. Endocrinology. 2011;152:2377\u201386.","journal-title":"Endocrinology"},{"key":"435_CR27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2337\/db08-1428","volume":"58","author":"GA Bewick","year":"2009","unstructured":"Bewick GA, Kent A, Campbell D, Patterson M, Ghatei MA, Bloom SR, et al. Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivity. Diabetes. 2009;58:840\u20136.","journal-title":"Diabetes"},{"key":"435_CR28","doi-asserted-by":"publisher","first-page":"E752","DOI":"10.1152\/ajpendo.00463.2007","volume":"294","author":"JA Reed","year":"2008","unstructured":"Reed JA, Benoit SC, Pfluger PT, Tsch\u00f6p MH, D\u2019Alessio DA, Seeley RJ. Mice with chronically increased circulating ghrelin develop age-related glucose intolerance. Am J Physiol Endocrinol Metab. 2008;294:E752\u201360.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"435_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1210\/en.2005-0973","volume":"147","author":"DL Drazen","year":"2006","unstructured":"Drazen DL, Vahl TP, D\u2019Alessio DA, Seeley RJ, Woods SC. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology. 2006;147:23\u201330.","journal-title":"Endocrinology"},{"key":"435_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1369-1600.2006.00041.x","volume":"12","author":"E Jerlhag","year":"2007","unstructured":"Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007;12:6\u201316.","journal-title":"Addict Biol"},{"key":"435_CR31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","volume":"58","author":"R Schlimgen","year":"2016","unstructured":"Schlimgen R, Howard J, Wooley D, Thompson M, Baden LR, Yang OO, et al. Risks associated with lentiviral vector exposures and prevention strategies. J Occup Environ Med. 2016;58:1159\u201366.","journal-title":"J Occup Environ Med"},{"key":"435_CR32","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","volume":"32","author":"MC Milone","year":"2018","unstructured":"Milone MC, O\u2019Doherty U. Clinical use of lentiviral vectors. Leukemia. 2018;32:1529\u201341.","journal-title":"Leukemia"},{"key":"435_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL 3rd, Strohl WR. Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs. 2017;31:317\u201334.","journal-title":"BioDrugs"},{"key":"435_CR34","doi-asserted-by":"publisher","first-page":"518909","DOI":"10.1155\/2013\/518909","volume":"2013","author":"C Delporte","year":"2013","unstructured":"Delporte C. Structure and physiological actions of ghrelin. Scientifica. 2013;2013:518909\u2013518909.","journal-title":"Scientifica"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00435-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00435-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00435-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:07:00Z","timestamp":1710461220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00435-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":34,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1038\/s41434-023-00435-9","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Animal Ethics Committee of the Western Sydney Local Health District (protocol code 4332.08.20 and date of approval on 28 August, 2020). The work was also approved by the Institutional Biosafety Committee of the Westmead Institute for Medical Research (Reference #WIMR-18-04 and date of approval on 26 April 2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}